68Ga-R10602

N/A

Report date: 2025/11/28 15:16:40

NME

Base Information

Drug Name68Ga-R10602

Drug Alias Name68Ga-R1060268Ga-R10602-101

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68Ga +[5]

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsHR-positive breast cancerBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesRadionetics Oncology Inc

China Registration ClassN/A

Develop Information

Active CompaniesRadionetics Oncology Inc

Inactive CompaniesN/A

Active IndicationsHR-positive breast cancerBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A